BANK VONTOBEL/CALL/SANOFI/100/0.1/20.12.24 Share Price

Warrant

DE000VM7HUN9

Market Closed - Boerse Frankfurt Warrants 19:01:37 04/07/2024 BST
0.3 EUR 0.00% Intraday chart for BANK VONTOBEL/CALL/SANOFI/100/0.1/20.12.24
Current month+7.14%
1 month+11.11%
Date Price Change
04/07/24 0.3 0.00%
03/07/24 0.3 +3.45%
02/07/24 0.29 -14.71%
01/07/24 0.34 +21.43%
28/06/24 0.28 +12.00%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 07:01 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM7HUN
ISINDE000VM7HUN9
Date issued 27/12/2023
Strike 100
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 0.32
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.62
Lowest since issue 0.144
Delta0.35x
Omega 9.602
Premium13.57x
Gearing27.16x
Moneyness 0.9100
Difference Strike 9
Difference Strike %+9.00%
Spread 0.07
Spread %18.92%
Theoretical value 0.3350
Implied Volatility 24.79 %
Total Loss Probability 70.70 %
Intrinsic value 0.000000
Present value 0.3350
Break even 103.35 €
Theta-0.01x
Vega0.02x
Rho0.01x

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.78%
Consensus